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Abstract
21The synthesis and spectral and magnetic characterization of VO complexes with Ibuprofen (2-(4-isobutylphenyl)propionic acid),
Naproxen (6-methoxy-a-methyl-2-naphthalene acetic acid) and Tolmetin (1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic acid) were
studied. The complexes [VO(Ibu) ]?5CH OH, [VO(Nap) ]?5CH OH and [VO(Tol) ] were obtained from methanolic solutions under2 3 2 3 2
nitrogen atmosphere. The biological activities of these complexes on the proliferation of two osteoblast-like cells in culture (MC3T3E1
and UMR106) were compared with that of the vanadyl(IV) cation. The complexes exhibited different effects depending on the
concentration and the cellular type, while no effect was observed for their parent drugs.  2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction drugs and exhibit an anti-ulcer activity. These complexes
show a lower toxicity than the inorganic forms of cop-
It is well known that most of the anti-inflammatory per(II). On the other hand, some studies suggest that
drugs are carboxylic acids in which the carboxylate group regular Ibuprofen intake may also be an effective chemop-
is available for metal–ligand interaction [1–3]. Ibuprofen reventive agent against breast cancer and can decrease
(2-(4-isobutylphenyl)propionic acid), Naproxen (6- non-small cell lung cancer growth in vitro [8].
methoxy-a-methyl-2-naphthalene acetic acid) and Tol- Vanadium is an ultramicrotrace bioelement with interest-
metin (1-methyl-5-(4-methylbenzoyl)-1H-pyrrole-2-acetic ing biological properties [9–12]. In mammals, vanadium is
acid) (see Fig. 1) are non-steroidal anti-inflammatory drugs
(NSAIDs) that exhibit favourable anti-inflammatory, anal-
gesic and antipyretic properties. The major clinical appli-
cation of NSAIDs is their action as anti-inflammatory
agents in muscle skeletal diseases [4]. There are a number
of recently published papers on the effects of NSAIDs in
bone-related tissues under different inflammatory condi-
tions [5–7].
Several transition metal complexes with NSAIDs have
been extensively studied since Sorenson [3] demonstrated
that copper(II) complexes are more active than their parent
*Corresponding author. Fax: 154-221-425-9485.
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liams). Fig. 1. Structures of Ibuprofen, Naproxen and Tolmetin.
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mainly stored in bones and kidneys [10]. For this reason it 2.2. Syntheses
is very interesting to study the biological effects of
vanadium compounds in bone-related cells. Using an in 2.2.1. [VO(Ibu) ]?5CH OH2 3
vitro model of osteoblast-like cells in culture, it has A solution of 2 mmol of Ibuprofen in 6 ml MeOH was
previously been shown that vanadium exerts a biphasic added to a methanolic VOSO ?5H O solution (10 ml, 14 2
effect: while low concentrations stimulate, high concen- mmol) under nitrogen atmosphere. The generated precipi-
trations induce inhibition of osteoblast growth and dif- tate Na SO was separated by centrifugation and dis-2 4
ferentiation as well as morphological transformations [13– carded. The violet solution was kept at 2208C overnight.
18]. The violet crystals formed were not suitable for X-ray
We have recently reported the synthesis and bioactivity diffraction analysis and their powder diagram showed a
of a new vanadyl(IV)–Aspirin complex (Asp-VO) [19]. highly amorphous character. Recrystallization procedures
This complex seems to be more potent than uncomplexed failed due to decomposition of the samples. Yield: 80%.
vanadyl salt in inhibiting the growth of osteoblast-like cells Anal. Calcd. for C H O V: C, 58.4%; H, 8.5%. Found:31 54 10
and regulating cell proliferation and differentiation [19]. C, 58.1%; H, 8.2%. Room temperature magnetic moment:
These effects are partially associated with the ability of 1.71 BM. MW : 637.calcd.
vanadium derivatives to indirectly induce phosphorylation
in tyrosine residues of proteins by inhibition of protein 2.2.2. [VO(Nap) ]?5CH OH2 3
tyrosine phosphatases (PTPases). In addition, the antineo- Naproxen methanolic solution (2 mmol, 20 ml) was
plastic effects of vanadium have been demonstrated both in added to a solution of VOSO ?5H O (1 mmol in 10 ml4 2
vitro and in vivo models. For instance, organometallic MeOH) under nitrogen atmosphere. Na SO precipitated2 4
complexes of vanadium(IV) linked to bis(cyclopen- immediately and the suspension was maintained with
tadienyl) moieties or vanadocenes [20] and oxovanadium constant stirring for 24 h under N atmosphere. Precau-2
compounds that included substituted phenanthroline and tions were taken to avoid alcohol evaporation. Sodium
2,29-bipyridine ligands induce apoptosis in human cancer sulphate was then separated by centrifugation and the final
cells [21]. violet solution was kept at 2208C overnight. A grey
The aim of this study was the synthesis and characteri- powder was formed, separated by filtration and washed
zation of new NSAIDs–vanadyl complexes. Moreover, the with cold MeOH. Yield: 60%. Anal. Calcd. for
effects of these complexes on osteoblast proliferation were C H O V: C, 56.0%; H, 6.7%. Found: C, 55.6%; H,33 46 12
determined in two cell lines in culture: the non-trans- 6.4%. Room temperature magnetic moment: 1.78 BM.
formed MC3T3E1 derived from mouse calvaria and the MW : 685.calcd.
tumoral UMR106 from a rat osteosarcoma. The results
were compared with those for the parent drugs. 2.2.3. [VO(Tol) ]2
The same procedure as for Naproxen-VO was per-
formed. The blue solution was kept at 2208C. A grey
powder was obtained in a few days with poor yield (ca.
2. Experimental 10%). The solid was filtered and washed with cold MeOH.
Anal. Calcd. for C H N O V: C, 62.2%; H, 4.8%; N,30 28 2 7
2.1. Materials and methods 4.8%. Found: C, 62.5%; H, 5.0%; N, 4.8%. Room tem-
perature magnetic moment: 1.99 BM. MW : 579.calcd.
Ibuprofen, Naproxen, Tolmetin (Sigma), and VOSO4
(Merck) were used as supplied. Tissue culture materials 2.3. Cell culture
were provided by Corning or Falcon. Dulbecco’s modified
Eagle’s medium (DMEM), trypsin, fetal bovine serum Rat osteosarcoma UMR106 and osteoblastic non-trans-
(FBS) and ethylenediamine-tetraacetic acid (EDTA) were formed mouse calvaria derived MC3T3E1 cells were
supplied by Gibco. All other chemicals used were of grown in DMEM supplemented with 10% (v/v) FBS and
analytical grade. antibiotics (100 U/ml penicillin and 100 mg/ml strep-
Electronic UV–vis and diffuse reflectance spectra were tomycin) in a humidified atmosphere of 95% air /5% CO .2
recorded on a Hewlett-Packard 8453 diode-array spec- Cells were grown at near-confluence (70–80%) and were
21trophotometer and a Shimadzu UV-300 spectrophotometer, subcultured using 0.1% trypsin–1 mM EDTA in Ca –
21respectively. Infrared spectra were recorded on a Perkin- Mg -free phosphate-buffered saline (PBS). For experi-
4 4Elmer 580B spectrophotometer using the KBr pellet ments, about 5.5310 cells /well (UMR 106) and 3.3310
technique. Room temperature magnetic susceptibility was cells /well (MC3T3E1) were plated onto 24-well plates.
determined with a Cahn-2000 balance, calibrated with After the culture reached 70% confluence, the cells were
Hg[Co(SCN) ] and at a magnetic field strength of 6 kG. washed twice with DMEM. Cells were incubated overnight4
Elemental analyses for carbon, hydrogen and nitrogen with vanadium compounds at different doses in serum-free
were performed using a Carlo Erba EA 1108 analyzer. DMEM.
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2.4. Cell proliferation assay b →b transition. The shift of the b →e and b →b bands2 1 2 2 1
to the red and blue, respectively, compared with that of
21A mitogenic bioassay was carried out as described by [VO(H O) ] , agrees with carboxylate coordination to2 5
Okajima et al. [22] with some modifications. Briefly, cells the metal center [24,25]. For the bioactivity studies the
in 24-well plates were washed with PBS and fixed with 5% solid complexes were dissolved in culture medium and
glutaraldehyde/PBS at room temperature for 10 min. Cells added in different concentrations to the cell monolayer.
were then stained with 0.5% crystal violet /25% methanol For this reason, the UV–vis spectra in DMEM medium for
for 10 min. The dye solution was then discarded and the the three complexes were measured. Table 1 shows the
plate was washed with water and dried. The dye in the electronic absorption bands of the complexes dissolved in
3cells was extracted using 0.5 ml /well 0.1 M glycine /HCl the cell culture medium. The solutions were prepared 10
buffer, pH 3.0 /30% methanol and transferred to test tubes. times more concentrated than those used for biological
Absorbance was read at 540 nm after a convenient sample assays, in a L/M molar ratio of 5:1. These conditions were
dilution. The correlation between cell number /well and the selected to allow detection by UV–visible electronic
absorbance at 540 nm of diluted extraction sample after spectroscopy and to reduce hydrolysis effects. These
crystal violet staining has been established previously [14]. spectra remain unchanged for 2 h. This period was chosen
Data are expressed as the mean6S.E.M. Statistical differ- because it is sufficient for cellular uptake of the complexes.
ences were analyzed using Student’s t-test. t-Tests were Inside the cells, the compounds are metabolised and the
performed to compare treated cultures with the untreated nature of the biologically active species is not fully
cultures. The recently prepared vanadyl(IV) complexes understood [15]. The diffuse reflectance spectra of the
were used to obtain fresh solutions to be added to the three solid complexes show the same pattern (Table 1).
culture dishes at the following concentrations: 0, 2.5, 5, 10, The differences observed in the positions of the band
25, 50, 75 and 100 mM. The studies were performed in this maxima can be attributed to solvatochromic effects. Never-
concentration range because we and other authors have theless, the above shifts are a general pattern observed in
demonstrated that higher concentrations of vanadium both types of solutions and in the solid state, suggesting
compounds are toxic and cause osteoblast death [18]. the same structure for the complexes under the three
experimental conditions.
3. Results and discussion Table 2
Infrared spectra of Ibuprofen, its sodium salt and the complex with
VO(IV)3.1. UV–vis spectra
HIbu NaIbu Ibu-VO Assignments
The UV–vis spectra were recorded in methanolic solu- 3497 sh n(OH), H O2
tions (see Table 1, L/M52:1). Using the well-known 3356 vs n(OH), H O2
3435 s n(OH), CH OHBallhausen and Gray MO scheme for C symmetry [23], 34v
21 1719 vs n(C=O)–COOHthe ligand field transitions in [VO(H O) ] can be2 5 1697 sh 1694 wassigned as follows: the band at lower energies corre- 1670 w
2sponds to the b →e transition and the second band to the2 1588 vs n (COO )as
1584 sh
1572 sh
2Table 1 1552 vs n (COO )as
UV–vis and diffuse reflectance spectra of [VO(Ibu) ]?5CH OH, 1548 sh2 3
[VO(Nap) ]?5CH OH and [VO(Tol) ] 1506 m 1521 sh 1509 m Ring mode2 3 2
as1461 m 1470 m 1458 m d CH3b →e b →b2 2 1 1451 w
a,b a,bIbu-VO 845 (25) 595 (14.5) 1419 s
c c 2840 565 1411 vs 1415 vs n (COO )s
[820] [570] 1379 m 1390 sh 1383 w
s1364 m 1364 m 1368 m d CH (isopropyl)b b 3Nap-VO 840 (17) 620 (10.2) 1329 m 1333 w 1333 wc c850 565 1321 s n(C–O)–COOH[810] [560] 1290 m 1290 m
b bTol-VO 835 (20.5) 610 (16) 1266 m 1258 w 1266 sh vphenyl, p-substituted
c c850 570 1231 vs d CHip
[840] [550] 1183 s 1188 w 1188 w nCH isopropyl
. . . . . . . . .21 21Electronic absorption bands in nm; absorptivity (M cm ) in 933 s n(V=O)parentheses; diffuse reflectance in brackets. . . . . . . . . .a Ref. [25]. 572 (br,s) n(V–O)b Methanolic solutions.
c Cell culture medium solutions. vs, very strong; s, strong; m, medium; w, weak; sh, shoulder; br, broad.
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Table 43.2. Infrared spectra
Infrared spectra of Tolmetin, its sodium salt and the complex with
VO(IV)The most important features of the infrared spectra of
HTol NaTol Tol-VO Assignmentsthe three complexes and the corresponding free ligands are
shown in Tables 2–4. 3514 br n(OH), H O2
1732 s n(C=O)–COOHThe O–H stretchings due to water or methanol can be
21 1701 vs n(C=O)observed in the 3600–3300 cm range.
1678 m 1665 sh n(C=O)The n(C=O) of the carboxylic acid group appeared at 1630 sh 1640 w
21ca. 1730–1720 cm for the free ligands. The assignments 1617 vs 1612 m 1610 sh
2of IR frequencies for the antisymmetric n (COO ) and 1605 shas
2 1597 ssymmetric n (COO ) stretching vibrations for the sodiums 21565 m 1590 vs n (COO )assalts and the complexes are given in the tables. The
1488 m 1489 m 1490 m Ring modepositions of these bands for the sodium salts and the as1459 m 1452 m 1455 s d CH321separation between them (D ca. 146 cm ) are consistent 1428 w 1430 m
2with an anionic carboxylate group. In the complexes, 1414 m 1410 s n (COO )s
2 21 2 1407 wn (COO ) occurs at |1590 cm and n (COO ) at |1412as s
21 21 1377 m 1379 sh 1375 s n(C–O)–COOH,cm with an average Dn value of |178 cm . The s
d CH3correlations between the Dn values and the carboxylate 1369 s
mode of bonding are essentially empirical [26]. For 1341 m
comparative purposes, in the case of metal complexes with 1306 w
1281 s 1291 mcarboxylate ligands other than acetates, it is important to
1268 m 1266 s vphenyl, p-substitutedconsider the Dn values of similar metallic complexes with
1237 m 1228 w 1237 s d CHipknown crystalline structures [27–31]. 1196 w 1191 m 1194 m
1178 m 1179 m 1181 m nCH
1155 m 1155 m 1155 m
Table 3 1131 w 1131 m
Infrared spectra of Naproxen, its sodium salt and the complex with . . . . . . . . .
VO(IV) 943 s n(V=O)
. . . . . . . . .HNap NaNap Nap-VO Assignments
545 m n(V–O)
3465 br n(OH), H O2
vs, very strong; s, strong; m, medium; w, weak; sh, shoulder; br, broad.3371 br n(OH), H O2
3452 br n(OH), CH OH3
1729 vs n(C=O)–COOH
The stretching frequencies n(V=O) are located at ca. 9401700 w 1709 w
211687 m cm for the three complexes. Complexes of vanadyl(IV)
1631 w 1631 w 1633 w cation with monodentate carboxylate ligands exhibit this
1606 m 1606 m 1605 sh frequency at higher values [31]. On the other hand, for1562 s
2 polymeric chains in which the V=O moieties are held1550 vs 1592 vs n (COO )as 21together by double acetate bridges, n(V=O) is ,900 cm .1507 w 1502 w 1506 w Ring mode
1482 w 1485 w 1484 w In these complexes, there is an interaction involving the
1471 w V–O bond itself and the neighbouring oxometal units
as1453 w 1453 w 1461 m d CH3 [32–36]. In the case of a coordination sphere around the1419 w
2 vanadium atom consisting of two chelate-sugar moieties1404 m 1412 s n (COO )s
s ligated through deprotonated hydroxyl atoms, the position1395 m 1393 m 1392 m d CH (isopropyl)3
s 211364 m 1369 w d CH (isopropyl) of the stretching frequencies are ca. 940–930 cm3
1347 m 1341 w 1346 w n(C–O)–COOH [37,38]. This suggests that the vanadyl complexes reported
1304 w here present the same type of chelate environment around1268 m 1265 m 1268 m
the metal center.1248 m
The V–O stretchings are located between 570 and 5451229 m 1231 w 1230 m d CHip
211215 s 1214 m cm .
1196 m 1197 w nCH isopropyl For Tolmetin, n(C=O) of the carbonyl group is located
1178 s 1175 m 21at 1701 cm for the free acid. This band is very sensitive1161 s 1162 m 1158 m
when electron donor or electron acceptor groups are. . . . . . . . .
attached to the ligand [39]. As expected, when the ligand is942 m n(V=O)
. . . . . . . . . deprotonated (as in the sodium salt) or coordinated to
21572 m n(V–O) vanadium, this band shifts to 1678 and 1665 cm ,
vs, very strong; s, strong; m, medium; w, weak; sh, shoulder; br, broad. respectively.
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3.3. Magnetic behaviour 3.4. Effect of NSAIDs–vanadyl(IV) complexes on
osteoblast growth
Measurements of the room temperature magnetic mo-
ments are good criteria to determine whether the car- The free ligands, Ibuprofen, Naproxen and Tolmetin
boxylate anion is acting as a bridge or chelate ligand. were tested on both osteoblast-like cell lines in the
Subnormal m values are indicative of the coupling concentration range 0–100 mM. These drugs did noteff
between metal ions as in the case of copper(II)-carboxylate inhibit or promote cell proliferation in the tested con-
adducts of the type [Cu(RCOO) L] [30,40]. For centration range. No statistical differences were observed2 2
NSAIDs–vanadyl complexes, the measured m are in the in comparison with the basal condition, without vanadiumeff
range 1.71–1.99 BM, in accordance with the values compounds (data not shown).
1expected for a d (s 5 1/2) system. When coupling be- On the other hand, the effects of the NSAIDs–VO(IV)
tween oxovanadium(IV) centers occurs, the room tempera- complexes on non-transformed mouse calvaria MC3T3E1
ture m values are lower [32–36]. Based on these results, and UMR106 rat osteosarcoma-derived cells are shown ineff
carboxylate bridging coordination has to be discarded. Fig. 2(A)–(C).
Fig. 2. Effects of Ibu-VO (A), Nap-VO (B), Tol-VO (C) and VO (D) on MC3T3E1 and UMR106 osteoblast-like cell proliferation. Values are expressed as
4a percentage of the basal value and represent the mean6S.E.M. (n59). Basal values (0 mM vanadyl complexes) are 3.3310 cells /well for MC3T3E1 and
45.5310 cells /well for UMR106 cells. For statistically significant differences, see text.
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MC3T3E1 cells: as can be seen, Ibu-VO (Fig. 2(A)) more sensitive to vanadium derivatives than the osteosar-
caused a biphasic effect in cell proliferation, being coma UMR106 cells.
stimulatory at lower concentrations (2.5 and 5 mM, P, The proliferative effect of vanadium(IV) complexes was
0.01) and cytotoxic at higher concentrations (75 and 100 also compared with the effect of the vanadium(IV) cation
mM, P,0.01). Nap-VO (Fig. 2(B)) also behaved in a on both cell lines (Fig. 2(D)). The addition of VO(IV) to
similar way, producing stimulation and inhibition of cell the culture media induced a significant stimulation of
proliferation at concentrations of 2.5 mM (P,0.01) and UMR106 cell proliferation at 2.5–75 mM (P,0.01). On
75–100 mM (P,0.01), respectively. On the contrary, the the contrary, in MC3T3E1 non-transformed cells, VO(IV)
complex Tol-VO (Fig. 2(C)) significantly inhibited the inhibited cell growth in a dose–response manner (Fig.
growth of MC3T3E1 cells at all the tested concentrations 2(D)). Another NSAID-VO derivative, the Asp-VO com-
(P,0.01) in a dose–response manner. plex [19], also exerted a biphasic effect on UMR106 cells.
UMR106 cells: Ibu-VO (Fig. 2(A)) significantly stimu- This complex stimulated cell growth at low doses (2.5–25
lated cell growth in a narrow range of concentrations (2.5 mM) and inhibited at over 50 mM concentration. In
–25 mM, P,0.01) and showed no significant effects at addition, Asp-VO, like VO(IV), significantly inhibited
higher values. Nap-VO (Fig. 2(B)) did not stimulate cell MC3T3E1 cells at all the tested concentrations.
growth at low doses, but it was the more potent cytotoxic
agent (P,0.01) at 50–100 mM concentrations. This effect
was even stronger than in MC3T3E1 non-transformed 4. Conclusionscells. On the other hand, Tol-VO (Fig. 2(C)) did not show
any statistically significant effect in the whole range of Three new vanadyl(IV) complexes with non-steroidalconcentrations in the UMR106 cell line. anti-inflammatory drugs, Ibuprofen, Naproxen, and Tol-In order to investigate further the Nap-VO-induced metin, were synthesized and characterized by means ofcytotoxic effect in both osteoblast cell lines, additional elemental analysis, UV–vis, diffuse reflectance and IRexperiments were performed in the 50–100 mM con- spectroscopies, as well as their magnetic behavior. Thecentration range. As can be seen from Fig. 3, this biological activity of these vanadium compounds wasvanadium(IV) derivative was the most potent inhibitor of tested on two osteoblast-like cells in culture through acell growth in osteosarcoma cells. This effect contrasts proliferation bioassay. Neither Tolmetin nor Tol-VO af-with the cytotoxic effect of most of the vanadium(IV) fected the UMR106 osteosarcoma cell growth. In non-complexes that we have previously reported in these two transformed cells, the complex inhibits cell proliferation incell lines, such as VO, BMOV and Asp-VO [16–19]. In a manner dependent on the concentration. This effect wasthose studies the non-transformed cell line was always similar to that induced by VO(IV). Ibu-VO was a stimulat-
ory agent at low concentrations for both cell lines.
However, this complex was cytotoxic at high doses for
MC3T3E1 cells. On the other hand, Nap-VO only stimu-
lated MC3T3E1 growth at the lower doses tested without
induction of proliferation in UMR106 cells. Above 50 mM,
this complex was cytotoxic to both cell lines. Surprisingly,
Nap-VO-induced cell inhibition was more pronounced in
UMR106 than in MC3T3E1 cells. The results of the
biological assays show that NSAIDs moderate vanadyl(IV)
action on osteoblast-like cells. Further experiments are in
progress in order to investigate the anti-carcinogenic
potential of Nap-VO in other tumoral cell lines.
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